HB4433, the Toxic-Free Beauty Act of 2025, would amend the Federal Food, Drug, and Cosmetic Act to prohibit cosmetics that contain certain intentionally added chemicals and certain contaminants. The bill targets a list of substances commonly associated with health concerns, including formaldehyde, methylene glycol, mercury compounds, certain parabens, phenylenediamines, styrene, toluene, triclosan, triclocarban, cyclotetrasiloxane, acetaldehyde, vinyl acetate, and ortho-phthalates, as well as formaldehyde-releasing preservatives. It also bars cosmetics containing contaminants such as 1,4-dioxane above 2 ppm, lead above specified thresholds, and asbestos or asbestos-contaminated talc at the lowest detectable level.
The bill defines key terms such as color cosmetic, general cosmetic, contaminant, ingredient, intentionally added, and ortho-phthalate, which would guide enforcement and interpretation. It would take effect for cosmetics introduced into interstate commerce on or after January 1, 2027. The measure also revises federal preemption rules to preserve state authority to restrict cosmetic ingredients and contaminants, and to allow states to continue or adopt stricter requirements than federal law in this area.
If enacted, the bill would expand federal cosmetic safety standards under the FDCA by creating new prohibited ingredients and contaminant limits for cosmetics sold in interstate commerce. It would affect manufacturers, distributors, and importers of cosmetic products, especially those using preservatives, fragrance-related chemicals, hair dye ingredients, and trace contaminants in color and general cosmetics. It would also preserve and reinforce state and local authority to regulate cosmetic ingredients, limiting federal preemption and allowing stricter state bans or reporting requirements to remain in force or be adopted.
The available context shows the bill was introduced and referred to the House Committee on Energy and Commerce, with no recorded committee transcript or vote history provided. Based on the bill’s structure and sponsor list, the measure appears to reflect a public-health and consumer-safety approach to cosmetics regulation. Because there are no recorded debates or votes in the provided materials, there is no documented opposition or support beyond the bill’s introduction.
The main likely point of contention is regulatory burden versus consumer safety: cosmetic manufacturers and industry stakeholders may object to the breadth of the ingredient bans, contaminant thresholds, and compliance costs, while supporters are likely to emphasize health risks from toxic chemicals and long-term exposure. Another possible issue is federalism, because the bill explicitly preserves state authority and narrows preemption, which could be welcomed by states with stricter cosmetic rules but opposed by those favoring a uniform national standard. No specific objections or amendments are shown in the provided record.